Potential Effects of Coronaviruses on the Cardiovascular System A Review

被引:1294
作者
Madjid, Mohammad [1 ]
Safavi-Naeini, Payam [2 ]
Solomon, Scott D. [3 ]
Vardeny, Orly [4 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Med, McGovern Med Sch, 6431 Fannin,MSB 1-246, Houston, TX 77030 USA
[2] Texas Heart Inst, Houston, TX 77025 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Univ Minnesota, Minneapolis, MN USA
关键词
ACUTE RESPIRATORY SYNDROME; CLINICAL CHARACTERISTICS; HOSPITALIZED-PATIENTS; VIRAL LOAD; SARS; INFLUENZA; PNEUMONIA; INFECTION; DISEASE; TRANSMISSION;
D O I
10.1001/jamacardio.2020.1286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) has reached a pandemic level. Coronaviruses are known to affect the cardiovascular system. We review the basics of coronaviruses, with a focus on COVID-19, along with their effects on the cardiovascular system. Observations Coronavirus disease 2019 can cause a viral pneumonia with additional extrapulmonary manifestations and complications. A large proportion of patients have underlying cardiovascular disease and/or cardiac risk factors. Factors associated with mortality include male sex, advanced age, and presence of comorbidities including hypertension, diabetes mellitus, cardiovascular diseases, and cerebrovascular diseases. Acute cardiac injury determined by elevated high-sensitivity troponin levels is commonly observed in severe cases and is strongly associated with mortality. Acute respiratory distress syndrome is also strongly associated with mortality. Conclusions and Relevance Coronavirus disease 2019 is associated with a high inflammatory burden that can induce vascular inflammation, myocarditis, and cardiac arrhythmias. Extensive efforts are underway to find specific vaccines and antivirals against SARS-CoV-2. Meanwhile, cardiovascular risk factors and conditions should be judiciously controlled per evidence-based guidelines. This narrative review provides an overview of the basics of coronaviruses, with a focus on coronavirus disease 2019 along with their effects on the cardiovascular system.
引用
收藏
页码:831 / 840
页数:10
相关论文
共 81 条
[1]  
[Anonymous], 2015, CORONAVIRUSES, DOI [DOI 10.1007/978-1-4939-2438-7_1, 10.1007/978-1-4939-2438-71, 10.1007/978-1-4939-2438-7_1]
[2]   Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020 [J].
Backer, Jantien A. ;
Klinkenberg, Don ;
Wallinga, Jacco .
EUROSURVEILLANCE, 2020, 25 (05) :10-15
[3]   Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis [J].
Badawi, Alaa ;
Ryoo, Seung Gwan .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 49 :129-133
[4]   Real estimates of mortality following COVID-19 infection [J].
Baud, David ;
Qi, Xiaolong ;
Nielsen-Saines, Karin ;
Musso, Didier ;
Pomar, Leo ;
Favre, Guillaume .
LANCET INFECTIOUS DISEASES, 2020, 20 (07) :773-773
[5]   Identification of New Respiratory Viruses in the New Millennium [J].
Berry, Michael ;
Gamieldien, Junaid ;
Fielding, Burtram C. .
VIRUSES-BASEL, 2015, 7 (03) :996-1019
[6]   Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19-United States, January-February 2020 [J].
Burke, Rachel M. ;
Midgley, Claire M. ;
Dratch, Alissa ;
Fenstersheib, Marty ;
Haupt, Thomas E. ;
Holshue, Michelle ;
Ghinai, Isaac ;
Jarashow, M. Claire ;
Lo, Jennifer ;
McPherson, Tristan D. ;
Rudman, Sara ;
Scott, Sarah ;
Hall, Aron J. ;
Fry, Alicia M. ;
Rolfes, Melissa A. .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (09) :245-246
[7]  
Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]
[8]  
CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]
[9]  
Centers for Disease Control and Prevention, COR DIS 2019 COVID 1
[10]  
Centers for Disease Control and Prevention, SARS 10 YEARS